This patent covers a cytokine cocktail, that contains midkine, amongst other classical hematopoietic cytokines, useful for the expansion of hematopoietic stem cells.
The cocktail may be used for the in vivo treatment of patients that are neutropenic or cytopenic, or may be used for the ex vivo expansion of hematopoietic stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.